Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Phage display technology: clinical applications and recent innovations.

Azzazy HM, Highsmith WE Jr.

Clin Biochem. 2002 Sep;35(6):425-45. Review.

PMID:
12413604
2.

Considerations on antibody-phage display methodology.

Conrad U, Scheller J.

Comb Chem High Throughput Screen. 2005 Mar;8(2):117-26. Review.

PMID:
15777175
3.

Phage display of combinatorial antibody libraries.

Rader C, Barbas CF 3rd.

Curr Opin Biotechnol. 1997 Aug;8(4):503-8. Review.

PMID:
9265732
4.

Direct selection of cDNAs from filamentous phage surface display libraries: potential and limitations.

Rhyner C, Kodzius R, Crameri R.

Curr Pharm Biotechnol. 2002 Mar;3(1):13-21. Review.

PMID:
11883503
5.

Phage display: concept, innovations, applications and future.

Pande J, Szewczyk MM, Grover AK.

Biotechnol Adv. 2010 Nov-Dec;28(6):849-58. doi: 10.1016/j.biotechadv.2010.07.004. Epub 2010 Jul 23. Review.

PMID:
20659548
6.

Antibody discovery: phage display.

Kretzschmar T, von Rüden T.

Curr Opin Biotechnol. 2002 Dec;13(6):598-602. Review.

PMID:
12482520
7.

Protein-protein interactions in hematology and phage display.

Mullaney BP, Pallavicini MG.

Exp Hematol. 2001 Oct;29(10):1136-46. Review.

PMID:
11602315
8.

Antibody phage display technology and its applications.

Hoogenboom HR, de Bruïne AP, Hufton SE, Hoet RM, Arends JW, Roovers RC.

Immunotechnology. 1998 Jun;4(1):1-20. Review.

PMID:
9661810
9.

Phage display for detection of biological threat agents.

Petrenko VA, Vodyanoy VJ.

J Microbiol Methods. 2003 May;53(2):253-62. Review.

PMID:
12654496
10.

Strategies for selection of antibodies by phage display.

Griffiths AD, Duncan AR.

Curr Opin Biotechnol. 1998 Feb;9(1):102-8. Review.

PMID:
9503596
11.

Molecular considerations for development of phage antibody libraries.

Tohidkia MR, Barar J, Asadi F, Omidi Y.

J Drug Target. 2012 Apr;20(3):195-208. doi: 10.3109/1061186X.2011.611517. Epub 2011 Sep 27. Review.

PMID:
21950316
12.

Designing scaffolds of peptides for phage display libraries.

Uchiyama F, Tanaka Y, Minari Y, Tokui N.

J Biosci Bioeng. 2005 May;99(5):448-56. Review.

PMID:
16233816
13.

Selective enrichment and high-throughput screening of phage surface-displayed cDNA libraries from complex allergenic systems.

Crameri R, Walter G.

Comb Chem High Throughput Screen. 1999 Apr;2(2):63-72. Review.

PMID:
10420976
14.

Phage display in pharmaceutical biotechnology.

Sidhu SS.

Curr Opin Biotechnol. 2000 Dec;11(6):610-6. Review.

PMID:
11102798
15.

Phage display of proteins.

Kościelska K, Kiczak L, Kasztura M, Wesołowska O, Otlewski J.

Acta Biochim Pol. 1998;45(3):705-20. Review.

16.

Phage displayed biomolecules as preventive and therapeutic agents.

Manoutcharian K, Gevorkian G, Cano A, Almagro JC.

Curr Pharm Biotechnol. 2001 Sep;2(3):217-23. Review.

PMID:
11530876
17.

Phage-display technology--finding a needle in a vast molecular haystack.

Rodi DJ, Makowski L.

Curr Opin Biotechnol. 1999 Feb;10(1):87-93. Review.

PMID:
10047512
18.

Identification of cancer targets and therapeutics using phage display.

Brissette R, Prendergast JK, Goldstein NI.

Curr Opin Drug Discov Devel. 2006 May;9(3):363-9. Review.

PMID:
16729733
19.

Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies.

Yau KY, Lee H, Hall JC.

Biotechnol Adv. 2003 Oct;21(7):599-637. Review.

PMID:
14516873
20.

Epitope discovery using monoclonal antibodies and phage peptide libraries.

Yip YL, Ward RL.

Comb Chem High Throughput Screen. 1999 Jun;2(3):125-38. Review.

PMID:
10420967

Supplemental Content

Support Center